<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02528149</url>
  </required_header>
  <id_info>
    <org_study_id>1308016</org_study_id>
    <nct_id>NCT02528149</nct_id>
  </id_info>
  <brief_title>Renal Arteries Dysplastic Aneurysms: Anatomopathological and Genetic Study</brief_title>
  <official_title>Renal Arteries Dysplastic Aneurysms: Anatomopathological and Genetic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fibromuscular dysplasia (FMD) is localized structural defects in the arterial wall, whose
      innate or acquired character is still unknown. This segmental non atheromatous injury, leads
      to stenosis of the arteries of small and medium caliber. Renal arteries are the most commonly
      affected with 60-75% of total fibrodysplasia. Three histological subtypes have been
      described: intimal, medial and peri-medial. They are not mutually exclusive and can be
      observed in the same patient.

      This is a rare blood disease, occurring in children and young adults. In this young
      population with long life expectancy, these aneurysmal lesion are associated with 10% risk of
      rupture. To date, no data have shown in the literature that FMD is link to genetic causes, or
      if there is specific histopathologic lesions for non-atherosclerotic renal artery aneurysms.

      To answer these questions, Cardiovascular Surgery Unit of the University Hospital of
      Saint-Etienne, French national reference center for renal artery surgery, in association with
      the Reference Center for Rare Vascular Disease in Paris, designed the first study for
      pathological and genetic characteristics of dysplastic renal artery aneurysms in young
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>anatomopathological characteristics of renal aneurysms</measure>
    <time_frame>day 1</time_frame>
    <description>Anatomopathological criteria is a composite outcome : Presence of a media thickness, the media disappearance zones, loss of smooth muscle cells (SMC) in the media with replacement by fibrosis, disorganization of SMC, aneurysms, dissections, discontinuity of the internal elastic lamina, and intimal thickening due to myointimal hyperplasia, abnormalities of proteins of the extracellular matrix.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>genetic markers in blood samples</measure>
    <time_frame>day 1</time_frame>
    <description>identify specific genetic markers (mutation, variant) to characterize genes involved in fibromuscular dysplasia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>genetic markers in aneurysm tissue</measure>
    <time_frame>day 1</time_frame>
    <description>identify specific genetic markers (mutation, variant) to characterize genes involved in fibromuscular dysplasia</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">34</enrollment>
  <condition>Fibromuscular Dysplasia</condition>
  <condition>Renal Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>patients with renal aneurysm</arm_group_label>
    <description>Patient with one or more renal artery aneurysm (RAA) operated and with tissue; adjacent part and aneurysm; cryopreserved. Blood sample performed at day 1.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>tissue of adjacent part and aneurysm of renal aneurysm</intervention_name>
    <description>the samples are collected during surgery of renal artery aneurysms. Th tissue is cryopreserved in liquid nitrogen before analysis</description>
    <arm_group_label>patients with renal aneurysm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <arm_group_label>patients with renal aneurysm</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples and adjacent part and aneurysm of renal aneurysms
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with one or more Renal artery aneurysm (RAA), not eligible for endovascular
        treatment, have been operated at the Hospital of Saint-Etienne, with tissue (adjacent part
        and aneurysm) cryopreserved in liquid nitrogen in renal lab and then sent in genetic lab in
        EHGP.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with one or more Renal artery aneurysm (RAA), not eligible for endovascular
             treatment, have been operated at the Hospital of Saint-Etienne, with tissue (adjacent
             part and aneurysm) cryopreserved in liquid nitrogen in renal lab and then sent in
             genetic lab in Georges Pompidou European Hospital (EHGP ).

          -  Patient (or parent/person having parental authority) Affiliate or entitled to a social
             security scheme.

          -  Signature of patient consent (or parents or holder of parental authority)

        Exclusion Criteria:

          -  Patient not included in the tissue collection in Georges Pompidou European Hospital
             (EHGP ).

          -  Patient refusing to participate in the study and / or genetic analysis or, for
             juvenile patients, parents or holder of parental authority refusing the minor patient
             to be involved in the study and / or genetic analysis.

          -  Patient with FMD whose samples in the tissue collection did not concern aneurysm.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Barral, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Saint-Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CH Henri Mondor</name>
      <address>
        <city>Aurillac</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Louis Pasteur</name>
      <address>
        <city>Bagnols sur Cèze</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Saint-Jacques</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint-Germain</name>
      <address>
        <city>Brive-La-Gaillarde</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier A. Gayraud</name>
      <address>
        <city>Carcassonne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH W. Morey</name>
      <address>
        <city>Chalon sur Saone</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Emile Roux</name>
      <address>
        <city>Le Puy en Velay</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Jeanne de Flandre</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de la mère et de l'enfant</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Schuman</name>
      <address>
        <city>Metz</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Niort</name>
      <address>
        <city>Niort</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2015</study_first_submitted>
  <study_first_submitted_qc>August 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2015</study_first_posted>
  <last_update_submitted>August 18, 2015</last_update_submitted>
  <last_update_submitted_qc>August 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fibromuscular Dysplasia</keyword>
  <keyword>dysplastic renal artery aneurysm</keyword>
  <keyword>renal artery aneurysms</keyword>
  <keyword>non atheromatous</keyword>
  <keyword>dysplastic</keyword>
  <keyword>anatomopathologic</keyword>
  <keyword>genetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Renal Artery Obstruction</mesh_term>
    <mesh_term>Fibromuscular Dysplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

